Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter
CONCLUSION: In addition to fracture prevention, anti-osteoporotic treatments for patients with vertebral fractures were associated with a reduction in mortality. A longer duration of treatment and the use of long-acting drugs was also associated with lower mortality.PMID:37120337 | DOI:10.1016/j.jfma.2023.04.004
Source: J Formos Med Assoc - Category: General Medicine Authors: Ta-Wei Tai Yi-Lun Tsai Chien-An Shih Chia-Chun Li Yin-Fan Chang Chun-Feng Huang Tien-Tsai Cheng Jawl-Shan Hwang Tsung-Hsueh Lu Chih-Hsing Wu Source Type: research
More News: Actonel | Chia | Databases & Libraries | General Medicine | Health Insurance | Insurance | Orthopaedics | Osteoporosis | Reclast | Risedronate | Study | Taiwan Health | Xgeva | Zometa